Kristina Torfgård, CEO and Gustaf Albèrt, CFO present at Aktiesdagarna
June 9, 2026
CEO Kristina Torfgård and CFO Gustaf Albèrt present IRLAB’s world-leading portfolio: five drug candidates with the potential to revolutionize the treatment of Parkinson’s disease (presentation in Swedish).
Published June 9, 2026.